Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation

Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation. A Randomized Controlled Trial

The aim of the study is to investigate physiological response, social/emotional response and general movements in preterm infants when they are given skin-to-skin contact with the mother (intervention) or standard care (incubator) right after delivery. Preterm infants will be randomized to either intervention or standard care group. Data on body temperature, blood glucose, hart rate, respiration rate and oxygen saturation will be obtained. In addition the infant will be video-recorded during the first 24 hours and at three months of age for analysis of the general movements.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Power calculations are based on a difference in Bayley Scale of Infant Development III, cognitive scale at two years corrected age of about 7,5 mean score =0.5 SD (α=0,05, β=0.80). Based on this analysis, 64 preterm infants are needed in each group to yield statistic significance. Allowing for withdrawals, the sample size is set to 68 in each group.

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Halifax, Canada
        • IWK Health Centre
      • Drammen, Norway
        • Nyfødt intensiv, Drammen sykehus
      • Kristiansand, Norway
        • Nyfødt intensiv, Sørlandet Sykehus
      • Trondheim, Norway
        • NICU St Olavs Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 7 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Preterm infants at 28-32 weeks of gestation (born 12-8 weeks before term)

Exclusion Criteria:

  • Infants who need immediate medical interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: skin-to-skin
immediately after birth the baby is laid on mother's chest for as long as justifiable medically to max 2 hours.
Active Comparator: standard care
after birth the baby is transferred to the neonatal intensive care unit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cognitive scorer at two years corrected age
Time Frame: 2 year
measured by Bayley Scales of Infant Development Third Edition (BSID III)
2 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in heart rate
Time Frame: 24 hours
24 hours
change in body temperature
Time Frame: 24 hours
24 hours
change in respiration frequency
Time Frame: 24 hours
24 hours
change in blood glucose
Time Frame: 24 hours
24 hours
general movements (GM) at 3 months corrected age
Time Frame: 3 months
assessed with the General Movement Assessment (GMA)
3 months
Nutrition
Time Frame: 1 year
based on a Norwegian questionnaire, based on a Norwegian national survey from The Norwegian Directorate of Health.
1 year
Social/emotional competence at three months corrected age
Time Frame: 3 months
measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)
3 months
Social/emotional competence at two years corrected age
Time Frame: 1 year
measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)
1 year
Social/emotional competence at two years corrected age
Time Frame: 2 years
measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)
2 years
Developmental skills at two years corrected age
Time Frame: 1 year
measured with the Ages and Stages Questionnaire: (ASQ)
1 year
Developmental skills at two years corrected age
Time Frame: 2 years
measured with the Ages and Stages Questionnaire: (ASQ)
2 years
Maternal anxiety
Time Frame: at discharge from hospital
measured with State-Trait Anxiety Inventory (STAI)
at discharge from hospital
Maternal anxiety
Time Frame: 3 months
measured with State-Trait Anxiety Inventory (STAI)
3 months
Maternal anxiety
Time Frame: 2 years
measured with State-Trait Anxiety Inventory (STAI)
2 years
Child Behaviour
Time Frame: 5 year
Measured with Child Behaviour Checklist
5 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Håkon Bergseng, md phd, Norwegian University of Science and Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2014

Primary Completion (Actual)

December 31, 2022

Study Completion (Anticipated)

December 1, 2025

Study Registration Dates

First Submitted

December 19, 2013

First Submitted That Met QC Criteria

December 28, 2013

First Posted (Estimate)

December 31, 2013

Study Record Updates

Last Update Posted (Actual)

January 20, 2023

Last Update Submitted That Met QC Criteria

January 19, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on standard care

3
Subscribe